Chronic Lymphocytic Leukemia app icon

Apps Like Chronic Lymphocytic Leukemia for iPhone and iPad

by At Point of Care, LLC★ 5.02 ratingsMedicalFreeData updated 2026-09-10

Chronic Lymphocytic Leukemia screenshots

Ranked alternatives

Showing 421–440 of 1,000 ranked alternatives.

  1. RenalGuard® AKI Calculator app icon

    RenalGuard® AKI Calculator

    RenalGuard Solutions, Inc.

    Calculate risk scores for AKI

    Calculate risk scores for acute kidney injury using clinical data. Input patient information to generate risk assessments. Provide guidance for healthcare professionals to inform clinical decisions.

    ★ 4.25 ratingsMedicalFreeData updated 2026-09-17
  1. Chiron Dr app icon

    Chiron Dr

    Thasa Technologies (Pty) Ltd

    ★ 0.00 ratingsHealth & FitnessFreeData updated 2026-09-06
  2. MH QuickLaunch app icon

    MH QuickLaunch

    MOBILE HEARTBEAT LLC

    Log in and access medical records

    Secure messaging enables clinical teams to communicate and collaborate in real time. Streamline log-in with for quick access. Access enterprise solutions to manage medical communications, track clinical workflows, and improve patient care.

    ★ 5.02 ratingsMedicalFreeData updated 2026-09-13
  3. GIHep app icon

    GIHep

    The Imlers, LLC

    Track liver health and manage GI conditions

    Track symptoms, medications, and lab results for liver and GI conditions. View treatment plans and appointment schedules. Share notes with healthcare providers and set reminders for follow-ups and tests.

    ★ 5.01 ratingsMedicalFreeData updated 2026-09-06
  4. VocalMD app icon

    VocalMD

    VocalMD Inc

    Consult doctors, manage health records, and track

    Patients can consult multiple doctors simultaneously in a virtual room. Schedule appointments, share medical records, and receive real-time updates. View test results and medication details.

    ★ 5.06 ratingsMedicalFreeData updated 2026-09-06

How we rank alternatives

Apps are ranked by functional similarity, category fit, rating confidence, and popularity.